Cohort of Patients Fulfilling at Least One Metabolic Syndrome Criterion FRESH-PEF5287-en Andriantsitohaina RAMAROSON Cohort of Patients Fulfilling at Least One Metabolic Syndrome Criterion METABOL FRESH-PEF5287-en 5287 FRESH-PEF5287 Ramaroson ANDRIANTSITOHAINA INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) Epidemiology France Portal (PEF) null Ramaroson;ANDRIANTSITOHAINA factor prospective complication relationship assessment Endocrinology Insulin-resistance syndromes Non-alcoholic fatty liver disease Behavioral determinants: Eating habits Behavioral determinants Main aim: to prospectively assess the role of hepatic steatosis in the onset of a metabolic syndrome (MS) and disorders linked to the kidney disease/MS combination Secondary objectives: - To measure the chief complication of hepatic steatosis, i.e. liver fibrosis; and to study the connection to MS, non-alcoholic fatty liver disease (NAFLD) and sleep apneoa syndrome (SAS). - To determine whether blood tests established for the non-invasive diagnosis of liver damage (steatosis, inflammation, liver fibrosis) in dysmetabolic liver disease also have prognostic value and may identify patients at risk of cardiovascular complications, malignancies, diabetes, or SAS. null France Pays de la Loire Individuals General population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Patients aged between 18 and 65 years old, with non-alcoholic fatty liver disease (NAFLD) and/or diabetes and/or sleep apnoea. Clinical data Participant-reported health data Health event/morbidity Health event/mortality Other Through organizations (health services or institutions schools businesses etc.) < 500 individuals Converting or copying information into a structured record Observational Study Observational Study Cohort study 237 Unknown Metadata-only access Access on specific project only